IIM
OLMA icon

INTECH Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

INTECH Investment Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Sell
24,087
-2,179
-8% -$29.2K ﹤0.01% 1581
2026
Q1 		$392K Buy
26,266
+1,068
+4% +$23.8K ﹤0.01% 1458
2025
Q4 		$630K Buy
25,198
+11,631
+86% +$207K 0.01% 1380
2025
Q3 		$133K Sell
13,567
-25,042
-65% -$150K ﹤0.01% 2184
2025
Q2 		$164K Buy
38,609
+14,297
+59% +$63.7K ﹤0.01% 2154
2025
Q1 		$91.4K Buy
24,312
+6,570
+37% +$33K ﹤0.01% 2336
2024
Q4 		$103K Buy
17,742
+4,056
+30% +$40.5K ﹤0.01% 2205
2024
Q3 		$163K Buy
+13,686
New +$175K ﹤0.01% 1782

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

INTECH Investment Management's OLMA Position: Q2 2026 in Review

INTECH Investment Management reduced its Olema Pharmaceuticals (OLMA) stake by 8.3% in Q2 2026, selling an estimated $29.2K and leaving 24,087 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

INTECH Investment Management first reported a position in OLMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $630K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • INTECH Investment Management held 24,087 shares of Olema Pharmaceuticals worth $301K as of Q2 2026.
  • INTECH Investment Management sold 2,179 Olema Pharmaceuticals shares in Q2 2026, an estimated $29.2K.
  • Olema Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1581 holding.
  • INTECH Investment Management first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Olema Pharmaceuticals position peaked at $630K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.